Ian Maher, MD
MOHS-Micrographic Surgery · Minneapolis, MNNPI 1598925513
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,136 of the $18,224 with a category attached, or 88.5%. Sun Pharmaceutical Industries Inc. accounts for 69.1% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $12,588, 4.5 times the $2,816 reported in 2020. Among mohs-micrographic surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $2024.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$13K
- Regeneron Healthcare Solutions, Inc.$3K
- Sanofi$3K
What the payments were for
- Consulting fees$16,13689%
- Travel & lodging$1,83910%
- Food & beverage$2491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 7 | $12,588 |
| Regeneron Healthcare Solutions, Inc. | 1 | $2,820 |
| Sanofi | 1 | $2,816 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,224 in reported general payments places this provider in the 95th percentile of 29 mohs-micrographic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 16 | $620 |
| Mupirocin | 15 | $124 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Minneapolis
- Chandler RundleMinneapolis$652
- Laura RezacRoseville$15K
- Edward SegerPlymouth$4K
- Addison DemerRochester$4K
- Anna-Bianca StashakRochester$902
- Ryan LaddRochester$808
- Bart EndrizziFridley$762
- Elliott CampbellRochester$732
- Julie CronkSaint Paul$523
- Adam SchmittPlymouth$516
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.